THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

Historic Medicare GLP-1 Program Launches July 1 with $50 Monthly Copays

Medicare's groundbreaking GLP-1 Bridge program starts July 1, 2026, offering Wegovy, Zepbound, and Foundayo for just $50 per month to eligible beneficiaries—marking the first time Medicare covers obesity medications.

The Dose·Jun 5, 2026

FDA Moves to Ban Large-Scale GLP-1 Compounding in Major Access Shift

By The Dose

Editorial cartoon: trending up arrow on teal/yellow waves

Medicare Launches $50 GLP-1 Coverage Starting July as Historic Access Barrier Falls

By GLP1 Clinics News Desk

Amber prescription bottle with white cap and visible pills

FDA Sends 30 Warning Letters to Telehealth Companies Over Misleading GLP-1 Claims

By GLP1 Clinics News Desk

Editorial cartoon: person walking through doorway on abstract shapes

The Dose

First Generic GLP-1 Hits Market as Liraglutide Shortage Continues

By RC Nelson·Apr 4, 2026

The Dose

Walgreens Disrupts GLP-1 Market with Subscription-Free Weight Management

By The Dose·Mar 26, 2026

The Dose

CMS BALANCE Model Targets Rural Access Gaps for GLP-1 Weight Loss Drugs

By GLP1 Clinics News Desk·Mar 23, 2026

Showing 3 of 7 articles.